Starling Marte

Starling Marte Undergoes Surgery To Address Core Muscle Injury

By Darragh McDonald | November 3, 2022 at 5:41pm CDT

The Mets announced to reporters, including Tim Healey of Newsday, that outfielder Starling Marte underwent surgery on Tuesday to address a core muscle injury he sustained in the second half of 2022. He is expected to be “without restriction” by Spring Training and Mike Puma of the New York Post relays that the standard recovery time is about eight weeks. Deesha Thosar of Fox Sports relays that this is related to a groin injury he sustained in June.

Signed in the offseason to a four-year, $78MM deal, Marte’s first year as a Met resulted in another strong season at the plate. He hit .292/.347/.468 for a wRC+ of 136, indicating he was 36% better than the league average hitter. The injury didn’t seem to hamper him much, as Marte’s month-to-month numbers were fairly steady until September, when a finger fracture limited him to just five games.

It doesn’t seem as though the Mets have reason to be terribly concerned about Marte going forward, given the timeline. Eight weeks from now would be around the time the calendar flips to 2023, giving Marte plenty of time to ramp up physical activities prior to the beginning of Spring Training in February.

Nonetheless, it is a situation worth monitoring given the outfield picture of the Mets. Incumbent center fielder Brandon Nimmo is a few days away from becoming a free agent, creating an opening up the middle. Some have wondered whether Marte could simply slide over to fill that gap, given his previous center field experience.

General manager Billy Eppler recently spoke on the subject, saying that the Mets are willing to play Marte up the middle. However, that path is not without risk. Marte is now 34 years old and a year removed from regular playing time in center, having spent most of 2022 in right. The year before, the advanced defensive metrics weren’t exactly wowed by his work in center, as he was pegged with a -4 by Defensive Runs Saved, 0.9 by Ultimate Zone Rating and zero Outs Above Average.

Perhaps it will end up being a moot point, since the Mets are reportedly making it a priority to retain Nimmo. Though if Marte’s progress is at all delayed, it might only increase the club’s desire to bring Nimmo back and keep Marte in right field.

Eppler: Mets Willing To Play Starling Marte In Center Field

By Anthony Franco | November 1, 2022 at 10:00pm CDT

The Mets are facing a number of high-profile free agents as the offseason looms. Among them is center fielder Brandon Nimmo, who’s easily the best non-Aaron Judge free agent option at the position. Nimmo and his representatives at the Boras Corporation will soon hear from a number of interested teams, as they’re allowed to formally speak with clubs other than the Mets five days after the conclusion of the World Series.

New York will surely keep in touch with Nimmo themselves, but they do have a potential in-house replacement if he departs. Starling Marte had played exclusively center field with the D-Backs, Marlins and A’s from 2020-21, but he moved to right field in deference to Nimmo after signing a four-year free agent deal last offseason. Marte didn’t start a single game in center field in 2022, logging all of five innings at the position. He played just under 1000 innings in right field.

After spending a year playing in a corner and having recently turned 34 years old, it’s fair to wonder if Marte’s days as a regular center fielder could be behind him. Speaking with Joel Sherman and Jon Heyman of the New York Post on The Show podcast this morning (Twitter link), Mets general manager Billy Eppler said the team would be comfortable deploying Marte as their primary center fielder in 2023 if necessary.

“Can Starling still play center field? Yeah, we believe he can,” Eppler told the Post. “That opens up some optionality for how we ultimately fill out that outfield. … We do have the ability to slide Marte over to center for a number of games, over 50% of the games. He’s got that ability to do that. … We are comfortable with him in center field.”

That’s certainly not a declaration the Mets are closing the book on retaining Nimmo. Eppler called re-signing Nimmo “not a closed case by any stretch of the imagination” and broadly spoke highly of his ability. One can argue for the Mets bringing back Nimmo as the center fielder and a top-of-the-lineup presence while keeping Marte and Mark Canha in the corners. Yet as Eppler noted, the possibly for Marte to slide back up the middle offers some additional flexibility in building out the roster if Nimmo does depart.

Public defensive metrics were mixed on Marte’s performance in right field during his debut season in Queens. Defensive Runs Saved credited him as three runs better than the average right fielder. Ultimate Zone Rating and Statcast’s Runs Above Average metric each pegged him below par, with UZR assigning him a -8 mark and Statcast putting him at -2. Eppler didn’t address Marte’s defensive metrics specifically but noted the outfielder battled some tightness in his left groin midway through the season. That perhaps explains in part a dip in his range that shouldn’t linger into 2023 after an offseason of recovery. Marte had zero MLB experience in right field before 2022, but he’d been consistently excellent in the other corner spot throughout his career.

His recent center field work has been mixed but serviceable. Between 2020-21, Marte logged 1509 1/3 innings in center. Both Statcast and UZR rated him a hair better than average, while DRS had him at a below-average but not intolerable -6 runs over that stretch.

In any event, the Mets will have to add an outfielder this offseason. Retaining Nimmo and keeping Marte and Canha in the corners would be the most straightforward outcome. Still, a nine-figure Nimmo deal could be beyond their liking as they also see players like Jacob deGrom, Edwin Díaz, Chris Bassitt and Taijuan Walker (the latter two of whom are locks to decline options) hit the market. New York has as much spending capacity as any team under owner Steve Cohen, but they’re virtually certain to see at least a couple players of note depart for loftier guarantees elsewhere.

If Nimmo is among that group, the Mets would have more to work with attacking the corner outfield market than adding a center fielder. Aside from Judge and Nimmo, the top free agent center fielder is likely Kevin Kiermaier, who’ll be bought out by the Rays after an injury-plagued year. A Cody Bellinger non-tender would add an excellent glove to the mix and vault him above Kiermaier as the #3 option, but Bellinger is a .193/.256/.355 hitter over his past 900 plate appearances. There also aren’t any clear upgrades who’ll be available in trade, with players like Cedric Mullins and Bryan Reynolds looking unlikely to move.

The corner outfield market is a bit deeper. Judge is obviously the prize, but the middle tier of free agency offers options like Andrew Benintendi, Mitch Haniger, Joc Pederson, Joey Gallo, Michael Brantley and old friend Michael Conforto. There’s also a wider pool of potential trade candidates, with Hunter Renfroe, Lourdes Gurriel Jr., Max Kepler and Anthony Santander among those who could be floated in talks over the coming months.

NL East Notes: Alcantara, Marte, Strider

By Mark Polishuk | October 1, 2022 at 6:15pm CDT

Sandy Alcantara’s season is officially over, as Marlins manager Don Mattingly told reporters (including the Miami Herald’s Jordan McPherson) today that the star right-hander won’t be pitching in the Marlins’ season finale on Wednesday. Alcantara pitched yesterday and would’ve been lined up to make his 33rd start in Wednesday’s game against the Braves, but Miami will instead close the book on what might end up as a Cy Young Award-winning campaign for the 27-year-old righty.

Over a league-high 228 2/3 innings, Alcantara has looked like an old-school workhorse in a sport increasingly dominated by pitch counts and bullpen usage. Alcantara has a 2.28 ERA, 53.6% grounder rate, and 5.6% walk rate to go along with that big workload, and he earned his second All-Star nod. While Miami is reportedly open to trading from its pitching depth this winter, Alcantara is known be off-limits, as his five-year, $56MM extension signed last November has made him a Marlins cornerstone.

NL Notes: Marte, Cardinals, Cruz

By Mark Polishuk | September 25, 2022 at 10:20pm CDT

The Mets issued an official statement on Starling Marte’s fractured right middle finger, saying that a recent CT scan “showed improved healing,” and that the center fielder “will continue baseball activities as tolerated.” This counts as good news, considering that Marte had to halt his first try at baseball activities last week, due to continued discomfort in his finger. Marte hasn’t played since his finger was hit by a Mitch Keller pitch on September 6.

It remains to be seen if Marte will be able to make it back before the end of the regular season, let alone by his stated target date of Friday, when New York begins a critical three-game series with the Braves that could decide the NL East. The Mets have continued to play well (a 12-6 record) since Marte was last in the lineup, but obviously having the All-Star center fielder back will boost the Mets’ chances of both capturing the division and potentially winning the World Series. There hasn’t yet been any indication that Marte could miss any postseason action, but he’ll have less time to heal if the Mets have to settle for a wild card, and don’t receive a first-round bye.

MLBTR Poll: Predicting The NL East Winner

By Anthony Franco | September 21, 2022 at 11:20pm CDT

As the regular season nears its conclusion, the playoff picture has mostly come into focus. Of the 12 teams currently in playoff position, 10 have a cushion of at least 4 1/2 games. The Padres and Phillies are working to hold off the Brewers for the final two Wild Card spots in the National League, but the rest of the teams currently in playoff position have put themselves in a great spot to reach the postseason barring a major collapse. There’s an outside shot the White Sox track down the Guardians in the AL Central or the Orioles get back into the AL Wild Card race, but it’d take a major turn of events over the next two weeks.

There’s a similar lack of intrigue in most of the division races. The Astros and Dodgers have already clinched their respective divisions. The Yankees, Guardians and Cardinals all hold leads of six-plus games in theirs. The only division race that promises plenty of intrigue down the stretch: the battle for the NL East.

Both the Mets and Braves are already guaranteed to make the postseason. They’re each likely to surpass 100 wins. Yet one of those teams will come up just shy of a division title, leaving them as the #4 seed in the National League. That means a three-game series against the #5 seed in a first-round Wild Card set under the playoff format introduced in this spring’s collective bargaining agreement. Obviously, both teams would much prefer to secure the division title (and almost certainly the NL’s #2 seed and accompanying first-round bye). Which one is the frontrunner for the division crown? Let’s take a look at the remaining road for each and their current health outlook.

Mets (95-56 record, +147 run differential)

Remaining schedule: at Oakland (three games), vs. Miami (two games), at Atlanta (three games), vs. Washington (three games)

The Mets have 11 games remaining. Eight of them are against teams 28 games or more below .500. The other three: a crucial series next weekend in Atlanta. New York welcomed back Max Scherzer from a brief injured list stint on Monday. He came out with six perfect innings against the Brewers, striking out nine, before being lifted due to a pitch count limitation. The Mets rotation is at full strength at the right time, pushing players like Tylor Megill and David Peterson into the bullpen.

The biggest current injury for the Mets is on the position player side. Right fielder Starling Marte has yet to return after suffering a non-displaced fracture in his right middle finger two weeks back. Anthony DiComo of MLB.com tweeted this afternoon that the All-Star outfielder is hopeful he’ll be back in time for next weekend’s series with the Braves. Center fielder Brandon Nimmo, meanwhile, left today’s game with left quad soreness. Mike Puma of the New York Post relays that he’s likely to go for imaging tomorrow but Nimmo downplayed the severity of the issue postgame.

Braves (93-56 record, +171 run differential)

Remaining schedule: at Philadelphia (four games), at Washington (three games), vs. Mets (three games), at Miami (three games)

The defending champions dug themselves an early hole with a mediocre first two months, but they’ve been incredible since the calendar flipped to June. They’re a staggering 70-28 over the past three and a half months, nearly erasing a deficit that was once as high as 10 1/2 games in the process. They’ve pulled even with the Mets in the loss column but have two fewer wins, leaving them with a bit more work to do to get ahead in the standings.

The Braves kick off a four-game set with the Phillies tomorrow. That’s a much more difficult series than any the Mets will play (aside from the Braves themselves), but Atlanta just swept Philly last weekend.

Like the Mets, Atlanta doesn’t have any key starting pitchers currently on the injured list. Rookie star Spencer Strider is battling some oblique soreness and had today’s scheduled start pushed back slightly, but there’s no indication an IL stint is currently under consideration. As with New York, Atlanta is down one star position player thanks to a fractured finger though. The Braves lost Ozzie Albies to a right pinky fracture over the weekend. There’s a chance he returns in the postseason but he’s not expected back before the end of the regular season. Rookie Vaughn Grissom filled in well in recent weeks while Albies was rehabbing a broken foot; he’ll be asked to do the same for the stretch run.

Tiebreaker procedure

The final three games between the Mets and Braves obviously loom as the largest remaining on the schedule for both clubs. Not only are they the most directly impactful in the standings, they also carry implications for the tiebreaker. The new CBA did away with the traditional Game 163 in favor of a tiebreaker system. If two clubs finish the season with the same record, the team with the better head-to-head mark gets the nod in the standings. The Mets lead this year’s season series 9-7, meaning Atlanta would need to sweep their final meeting to secure the tiebreaker.

How does the MLBTR readership expect things to play out? Which team will celebrate an NL East crown two weeks from now?

(poll link for app users)

Mets Notes: Marte, Megill, Nogosek, Givens

By Mark Polishuk | September 17, 2022 at 7:56pm CDT

Starling Marte attempted to start some baseball activities a few days ago, but the outfielder told reporters (including MLB.com’s Anthony DiComo) that the hitting and throwing drills were stopped since Marte’s fractured right middle finger “was still bothering me a good amount.” Since Marte’s injured-list placement was retroactive to September 7, he won’t be activated after just the minimum 10 days, and it isn’t yet certain when or even if Marte could be back before the end of the regular season.

For his part, Marte feels he will be able to play again, though manager Buck Showalter was more circumspect about the possibility. Naturally, getting Marte back onto the field as soon as possible would be ideal for all parties, especially if he can get some swings under his belt to ensure that his finger is fully healed heading into the playoffs. But, with a postseason trip all but officially assured, the team isn’t going to rush Marte back, since a re-aggravation of the injury could threaten his availability for October.

The Mets are trying to hold off the Braves for first place in the NL East, and the division crown carries even more importance given the new playoff format. While a late surge from the NL Central-leading Cardinals can’t be ruled out, the NL East winner is likely to finish with the second-best record in the National League, and will thus earn a first-round bye. That bye is valuable for countless reasons, including the fact that getting over a full week off would allow a team more time to get its players (like Marte) rested and recovered from injuries. Of course, not having Marte available will make it all the more difficult for New York to stay ahead of Atlanta down the stretch.

While Marte’s status is still a question mark, the Mets are at least getting some reinforcements back on the pitching side. Max Scherzer is tentatively scheduled to be activated from the 15-day IL in time to start Monday’s game against the Brewers, and Tylor Megill is also slated to be activated from the 60-day IL when the series begins in Milwaukee.

Megill suffered a shoulder strain in mid-June, and after starting all 27 games of his brief MLB career, the righty is being targeted for a bullpen role upon his return. Between his shoulder injury and another long-month IL stint due to biceps inflammation, Megill has barely pitched in 2022, with just 41 1/3 innings over his nine appearances. While his SIERA is an impressive 3.28 and his strikeout and walk rates are both above-average, Megill’s real-world numbers include a 5.01 ERA.

The Mets also welcomed righty reliever Stephen Nogosek back from the 15-day IL today, and played Mychal Givens on the injured list in the corresponding move. There was no stated reason for Givens’ placement, indicating that the right-hander has been placed on the COVID-related version of the IL. It isn’t known if Givens has tested positive for COVID-19, or is just suffering from symptoms.

Nogosek has missed the last four weeks due to an oblique strain. Now in his third MLB season, Nogosek has a career-high 19 1/3 innings, and a solid 2.79 ERA. New York has shuttled Nogosek up and down from Triple-A on multiple occasions this year, but with the Triple-A season almost over, Nogosek figures to stick in the majors and provide more depth in the Mets’ bullpen.

Mets Place Starling Marte On 10-Day Injured List

By Mark Polishuk | September 10, 2022 at 3:18pm CDT

The Mets have placed Starling Marte on the 10-day injured list, with the placement backdated to September 6. Marte’s IL stint opens a roster spot for prospect Mark Vientos, whose promotion was reported earlier today.

Marte hasn’t played since Tuesday, when he suffered a partial, non-displaced fracture in his right middle finger after being hit by a pitch by Pirates righty Mitch Keller. New York delayed in placing Marte on the IL in the hopes that he could recover enough to return to the lineup without an extended absence, but Marte still seemed very limited in terms of baseball activities. Newsday’s Tim Healey wrote prior to Friday’s game, Marte only “participated lightly in pregame drills” without any throwing or swinging.

The veteran outfielder will now get a full week off to recuperate, though given the nature of the injury, it isn’t a given that Marte will spend only the minimum amount of time on the injured list. The Mets surely don’t want to rush Marte back and risk further injury, which would then possibly put Marte’s availability for the playoffs in question. While the Mets are in a tight race with the Braves for the NL East title, the Mets are basically a lock to reach the postseason as at least a wild card team, and Marte will be a big part of any push throughout October.

Through 505 plate appearances, Marte is hitting .292/.347/.468 with 16 homers. This translates to a 134 wRC+, tying the career-best mark Marte posted just last season. Marte was named to his second All-Star roster earlier this summer. It has been an immediate impact for Marte in Queens, and the Mets’ four-year, $78MM free agent deal with the outfielder back in November currently looks like one of the winter’s wisest investments.

Tyler Naquin has taken over in right field in Marte’s absence, and it seems likely that the left-handed hitting Naquin and the right-handed hitting Darin Ruf will work in a platoon until Marte is able to return. The two trade deadline acquisitions have pronounced splits over their careers, and for 2022, Naquin is hitting .264/.329/.495 in 228 PA against righties, while Ruf has slashed .224/.329/.455 in 167 PA against southpaws.

Starling Marte Diagnosed With Non-Displaced Finger Fracture

By Anthony Franco | September 7, 2022 at 9:25pm CDT

Mets outfielder Starling Marte has been diagnosed with a partial non-displaced fracture of the middle finger on his right hand, the team informed reporters (including Steve Gelbs of SNY). The club currently considers him day-to-day, although it remains to be seen if he’ll eventually require a stint on the injured list.

Marte suffered the injury last night, when he was hit on the hand by a 96 MPH fastball from Pittsburgh’s Mitch Keller. He came out of the game a couple innings later, and he sat out today’s doubleheader. The Mets haven’t provided a timetable as to when they expect Marte to be ready for game action, although it’s seemingly encouraging they’re not immediately placing him on the injured list. The expansion of active rosters in September from 26 to 28 players gives the Mets a bit more leeway to give Marte a few days, particularly with an off day tomorrow to reassess his condition.

Signed to a four-year, $78MM deal over the winter, Marte has had an All-Star first season in Queens. He’s hitting .292/.347/.468 through 505 trips to the plate, on par with the best offensive seasons of his career. The star outfielder has connected on 16 homers, 24 doubles and five triples. He’s chipped in 18 stolen bases (albeit with nine caught stealings) and served as the club’s primary right fielder and #2 hitter.

The Mets turned to Tyler Naquin in right field today, and he’d presumably pick up the majority of playing time if Marte’s forced out of action. The lefty-hitting Naquin can split time with the right-handed Darin Ruf in the corner opposite Mark Canha, with Brandon Nimmo continuing to man center field.

New York has been hit with a couple notable injury situations in recent days. They placed Max Scherzer on the 15-day injured list with side fatigue this morning. At 87-51, the Mets are a lock to make the playoffs, but they’re in a tight NL East battle with the defending World Series champions. New York holds a half-game lead on the Braves in a race for the division title and accompanying first-round bye.

List Of All-Star Roster Replacements

By Mark Polishuk | July 17, 2022 at 7:27pm CDT

7:25PM: Freddie Freeman is also joining the NL roster, as the league announced that the Dodgers first baseman is replacing Starling Marte.

4:04PM: The league announced that the Cardinals’ Miles Mikolas has now been added to the NL roster, taking the spot of Brewers righty Corbin Burnes.

July 17, 1:15PM: The Mariners have announced that Ty France will be joining the festivities as well. MLB later announced the addition as well, noting that he is replacing Mike Trout. With Trout not taking part, Byron Buxton will move into the starting center fielder role for the American League.

10:05AM: MLB has announced three more additions, with one of them being the previously reported addition of Williams. The other two are closers: Liam Hendriks of the White Sox and Jordan Romano of the Blue Jays. Those three will replace Gerrit Cole, Justin Verlander and Max Fried.

July 16, 11:01PM: Brewers reliever Devin Williams has also been named to the NL roster, ESPN’s Jeff Passan reports (Twitter link).

7:11:PM: Four replacements were announced to the All-Star rosters, taking the spots of four other players who won’t be part of the Midsummer Classic. Dodgers left-hander Tyler Anderson, Padres infielder Jake Cronenworth, and Braves third baseman Austin Riley will be joining the National League’s team, while Blue Jays second baseman Santiago Espinal has been named to the American League’s roster.

Espinal is replacing Jose Altuve, who was hit in the knee by a pitch on Thursday. Altuve sat out Friday’s action and is back in the Astros lineup tonight as the DH, but even though he is well enough to play, Altuve and the Astros will use the All-Star break to get the second baseman fully back to 100 percent. Altuve had been voted in as the AL’s starter at second baseman, but now the Guardians’ Andres Gimenez take over as the starter for Tuesday’s game.

Jazz Chisholm was voted as the NL’s starting second baseman, but the Marlins standout will also be missing the game due to his lower back injury. Chisholm has been on the 10-day injured list since June 28, but he has been working out at the Marlins’ spring camp, and taking part in baseball activities. There isn’t a set timeline for Chisholm’s return, but the team is hopeful Chisholm can be activated for the start of the second half. With Chisholm out, Jeff McNeil becomes the NL’s new starter at the keystone, while Cronenworth will take over the backup infield role.

Giants lefty Carlos Rodon is also battling injury, opening the door for Anderson to receive the first All-Star nod of his seven-year career. Rodon has both a blister and a split nail on the middle finger of his throwing hand, and told Henry Schulman and other reporters that he is skipping the ASG in order to give the injury time to properly heal. There isn’t yet any indication that Rodon might require a visit to the injured list, and since Rodon last pitched on Thursday, he’ll receive at least a full week off between starts.

Riley was perhaps the most prominent omission from the original All-Star roster, given how the Braves slugger has posted some huge numbers over the first half. However, as it often the case with “snubs,” the situation sorted itself out once other players started to drop out. Riley will be taking the place of Nolan Arenado, as the Cardinals third baseman will use the break to rest a lingering back problem.

East Notes: Castillo, Jays, Orioles, Marte, Kiermaier, Nationals

By Mark Polishuk | July 10, 2022 at 11:07pm CDT

Luis Castillo was a Blue Jays trade target last winter, and unsurprisingly, Toronto continues to have interest in Castillo’s services, according to USA Today’s Bob Nightengale. Though Castillo missed the first month of the season due to shoulder soreness, he has been in strong form with a 2.92 ERA over 71 innings, even if his Statcast numbers aren’t quite as reflective of top-notch performance. Castillo’s walk rate and hard-contact numbers are only okay, though his strikeout rate (25.3%) is well above league average and he still has elite fastball velocity.

The Reds right-hander is one of the very best players (let alone pitchers) expected to be available as the deadline approaches, making him a natural fit for a Toronto club in sore need of pitching upgrades. Between Hyun Jin Ryu’s Tommy John surgery and underwhelming performances from Jose Berrios and Yusei Kikuchi, the faulty rotation has been the chief reason for the Jays’ struggles in the last month, which is why Nightengale writes that the Blue Jays “are expected to be the most aggressive team pursuing starting pitching help.” Last summer’s trade for Berrios is an example of how the Toronto front office hasn’t been hesitant to pay a big price for a player they want and need, though the Blue Jays will face plenty of competition for Castillo’s services.

More from both the AL East and NL East…

Also from Nightengale, the Orioles’ surprisingly strong play seemingly hasn’t changed the club’s long-term plans, as Baltimore is “expected to unload” several notable veterans. The list of names includes both impending free agents like Trey Mancini, Rougned Odor, and Jordan Lyles, plus more controllable players like Anthony Santander and All-Star closer Jorge Lopez. It’s safe to assume that the price tag will be a lot higher for Lopez and Santander than the others, but regardless, the O’s likely aren’t going to change course and start thinking about a playoff push.
Starling Marte left Saturday’s game due to a groin injury, and Marte wasn’t in the Mets lineup on Sunday. However, Marte is only day-to-day, as manager Buck Showalter told reporters (including MLB.com’s Anthony DiComo) that an MRI revealed only minor inflammation and no serious damage. Marte has been a big contributor in his first year in New York, and his first-half performance earned him a slot on the NL All-Star team earlier today. With this groin injury lingering, however, Marte might opt to skip the game to rest up over the break.
Kevin Kiermaier was placed on the 10-day injured list earlier today, marking the second time this month that a nagging hip injury has put the Rays outfielder on the shelf. Kiermaier told reporters (including Marc Topkin of the Tampa Bay Times) that he received a cortisone shot during his first IL stint, but now that the issue has returned, he’ll be visiting a specialist to further explore the injury. “There’s just a lot of unknowns right now with what’s to come….I don’t really know what the future holds, to be quite honest,” Kiermaier said, noting that surgery was a possibility. A major procedure could quite possibly end Kiermaier’s season, and thus maybe his tenure with the Rays altogether, as 2022 is the final guaranteed year of his contract. Kiermaier has spent all 13 of his pro seasons in the Tampa organization, though that tenure has involved several injury absences.
There hasn’t been much public information revealed about the Nationals’ possible sale, but billionaire Michael B. Kim is the first name linked to the list of potential buyers, according to Barry Svrluga and Chelsea Janes of The Washington Post. Kim and another bidding group have met in person with team officials already, and a third group is also slated for in-person meetings later in July. Though there seems to be an increasing feeling that the Lerner family will indeed sell the Nationals, it is still early in the process, since “as many as five or six individuals or groups are expected to meet with club officials.”

Load More Posts

Show all

Headlines

Starling Marte

Navigation

MLBTR INFO

Connect